Hong Kong Pharma Digital ... (HKPD)
NASDAQ: HKPD
· Real-Time Price · USD
1.25
0.00 (0.00%)
At close: Oct 15, 2025, 3:48 PM
1.23
-1.45%
After-hours: Oct 15, 2025, 07:18 PM EDT
Hong Kong Pharma Digital Technology Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
| Period Ending | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
Revenue | 20.31M | 16.69M | 12.56M |
Cost of Revenue | 17.9M | 13.13M | 9.82M |
Gross Profit | 2.42M | 3.56M | 2.74M |
Operating Income | 132.04K | 1.61M | 1.04M |
Interest Income | 1.74K | 474.00 | 219.00 |
Pretax Income | 36.11K | 1.53M | 1.02M |
Net Income | -27.06K | 1.33M | 998.2K |
Selling & General & Admin | 2.22M | 1.89M | 1.76M |
Research & Development | n/a | n/a | n/a |
Other Expenses | 67.26K | 60.95K | -62.95K |
Operating Expenses | 2.28M | 1.95M | 1.7M |
Interest Expense | 97.67K | 82.77K | 23.24K |
Selling & Marketing Expenses | n/a | n/a | n/a |
Cost & Expenses | 20.18M | 15.08M | 11.51M |
Income Tax Expense | 63.17K | 196.25K | 22.57K |
Shares Outstanding (Basic) | 9.02M | 7.37M | 11M |
Shares Outstanding (Diluted) | 10.21M | 7.37M | 11M |
EPS (Basic) | -0.00 | 0.18 | 0.09 |
EPS (Diluted) | -0.00 | 0.18 | 0.09 |
EBITDA | 1.21M | 2.53M | 1.76M |
EBIT | 133.78K | 1.61M | 1.04M |
Depreciation & Amortization | 1.07M | 925.58K | 714.59K |
Source: Financial Modeling Prep. Financial Sources.